These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 27683190

  • 1. Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density.
    Hamilton JL, Ul-Haq MI, Creagh AL, Haynes CA, Kizhakkedathu JN.
    Macromol Biosci; 2017 Mar; 17(3):. PubMed ID: 27683190
    [Abstract] [Full Text] [Related]

  • 2. In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.
    Hamilton JL, Imran Ul-Haq M, Abbina S, Kalathottukaren MT, Lai BF, Hatef A, Unniappan S, Kizhakkedathu JN.
    Biomaterials; 2016 Sep; 102():58-71. PubMed ID: 27322959
    [Abstract] [Full Text] [Related]

  • 3. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
    Rossi NA, Mustafa I, Jackson JK, Burt HM, Horte SA, Scott MD, Kizhakkedathu JN.
    Biomaterials; 2009 Feb; 30(4):638-48. PubMed ID: 18977029
    [Abstract] [Full Text] [Related]

  • 4. Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo.
    Imran ul-haq M, Hamilton JL, Lai BF, Shenoi RA, Horte S, Constantinescu I, Leitch HA, Kizhakkedathu JN.
    ACS Nano; 2013 Dec 23; 7(12):10704-16. PubMed ID: 24256569
    [Abstract] [Full Text] [Related]

  • 5. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD, Evans RW, Evans PJ, Hider RC.
    Biochem J; 2008 Jan 15; 409(2):439-47. PubMed ID: 17919118
    [Abstract] [Full Text] [Related]

  • 6. First human studies with a high-molecular-weight iron chelator.
    Dragsten PR, Hallaway PE, Hanson GJ, Berger AE, Bernard B, Hedlund BE.
    J Lab Clin Med; 2000 Jan 15; 135(1):57-65. PubMed ID: 10638695
    [Abstract] [Full Text] [Related]

  • 7. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
    Sarbisheh EK, Salih AK, Raheem SJ, Lewis JS, Price EW.
    Inorg Chem; 2020 Aug 17; 59(16):11715-11727. PubMed ID: 32799484
    [Abstract] [Full Text] [Related]

  • 8. High molecular weight polyglycerol-based multivalent mannose conjugates.
    Kizhakkedathu JN, Creagh AL, Shenoi RA, Rossi NA, Brooks DE, Chan T, Lam J, Dandepally SR, Haynes CA.
    Biomacromolecules; 2010 Oct 11; 11(10):2567-75. PubMed ID: 20804173
    [Abstract] [Full Text] [Related]

  • 9. Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.
    Liu Z, Lin TM, Purro M, Xiong MP.
    ACS Appl Mater Interfaces; 2016 Oct 05; 8(39):25788-25797. PubMed ID: 27623539
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cell Permeable Imidazole-Desferrioxamine Conjugates: Synthesis and In Vitro Evaluation.
    Pramanik S, Chakraborty S, Sivan M, Patro BS, Chatterjee S, Goswami D.
    Bioconjug Chem; 2019 Mar 20; 30(3):841-852. PubMed ID: 30762349
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral Non-absorbable Polymer-Deferoxamine Conjugates for Reducing Dietary Iron Absorption.
    Cui S, Liu Z, Nagy T, Agboluaje EO, Xiong MP.
    Mol Pharm; 2023 Feb 06; 20(2):1285-1295. PubMed ID: 36622899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluorene methoxycarbonyl-PEG-deferoxamine conjugates "hitchhike" with albumin in situ for iron overload therapy.
    Xu L, Guan R, Yu B, Li Y, Liu H, Jiang Y.
    Int J Pharm; 2022 Sep 25; 625():122136. PubMed ID: 36029994
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.
    Alta RY, Vitorino HA, Goswami D, Liria CW, Wisnovsky SP, Kelley SO, Machini MT, Espósito BP.
    PLoS One; 2017 Sep 25; 12(2):e0171729. PubMed ID: 28178347
    [Abstract] [Full Text] [Related]

  • 20. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D, Ponka P, Baker E.
    Cancer Res; 1994 Feb 01; 54(3):685-9. PubMed ID: 8306330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.